Document Detail


Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.
MedLine Citation:
PMID:  23202739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability and is also linked to other neurologic and psychiatric disorders. FXS is caused by a triplet expansion that inhibits expression of the FMR1 gene; the gene product, FMRP, regulates mRNA metabolism in the brain and thus controls the expression of key molecules involved in receptor signaling and spine morphology. While there is no definitive cure for FXS, the understanding of FMRP function has paved the way for rational treatment designs that could potentially reverse many of the neurobiological changes observed in FXS. Additionally, behavioral, pharmacological, and cognitive interventions can raise the quality of life for both patients and their families.
Authors:
Claudia Bagni; Flora Tassone; Giovanni Neri; Randi Hagerman
Related Documents :
11592979 - Elimination of ergovaline from a grass-neotyphodium endophyte symbiosis by genetic modi...
1537349 - Cloning of the complete biosynthetic gene cluster for an aminonucleoside antibiotic, pu...
19421329 - Initiation of methylglucose lipopolysaccharide biosynthesis in mycobacteria.
10863099 - The fk520 gene cluster of streptomyces hygroscopicus var. ascomyceticus (atcc 14891) co...
23039899 - Circadian genes period 1 and period 2 in the nucleus accumbens regulate anxiety-related...
7808389 - Functional assignment of erwinia herbicola eho10 carotenoid genes expressed in escheric...
9815619 - Altered p16/mts1/cdkn2 and cyclin d1/prad-1 gene expression is associated with the prog...
21075879 - Dynamic analysis of the lactococcus lactis transcriptome in cheeses made from milk conc...
23315209 - Analysis of dormant bud (banjhi) specific transcriptome of tea (camellia sinensis (l.) ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-12-03
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  122     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-03     Completed Date:  2013-02-04     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4314-22     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Autistic Disorder / genetics
Early Diagnosis
Epigenesis, Genetic
Fragile X Mental Retardation Protein / genetics
Fragile X Syndrome / diagnosis,  genetics*,  metabolism,  therapy
Humans
Molecular Targeted Therapy
Synaptic Transmission
Grant Support
ID/Acronym/Agency:
3UL1 RR024146-04S4/RR/NCRR NIH HHS; GGP10150//Telethon; HD02274/HD/NICHD NIH HHS; HD036071/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/FMR1 protein, human; 139135-51-6/Fragile X Mental Retardation Protein
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular pathogenesis of pulmonary arterial hypertension.
Next Document:  Multistructural hot spot characterization with FTProd.